Measuring Blood Pressure in Pregnancy Using Mercury and Automated Device
Not Applicable
Completed
- Conditions
- HypertensionPregnancyPre Eclampsia
- Interventions
- Device: Automated blood pressure recording device Omron HEM 705CP
- Registration Number
- NCT00809666
- Lead Sponsor
- St George Hospital, Australia
- Brief Summary
The aim of the PRAM study was to determine whether women diagnosed with hypertension in pregnancy, using the traditional mercury device, have the same pregnancy outcomes when blood pressure is measured by either an automated device or a mercury device throughout the pregnancy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 220
Inclusion Criteria
- women with a diagnosis of hypertension in pregnancy
Exclusion Criteria
- non-pregnant and normotensive pregnancy women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Mercury Automated blood pressure recording device Omron HEM 705CP All subsequent blood pressure recording done using mercury sphygmomanometry
- Primary Outcome Measures
Name Time Method The primary maternal outcome measure was the number of women having any episode of severe hypertension (BP ³ 170/110mmHg).
- Secondary Outcome Measures
Name Time Method Secondary end points included gestation at birth, caesarean section and induction of labour rates.
Trial Locations
- Locations (1)
St George Hospital
🇦🇺Sydney, New South Wales, Australia